Molecular Characterization of Three Recombinant Isolates of Avian Leukosis Virus Obtained from Contaminated Marek's Disease Vaccines
- 1 June 2008
- journal article
- Published by American Association of Avian Pathologists (AAAP) in Avian Diseases
- Vol. 52 (2), 245-252
- https://doi.org/10.1637/8100-083107-reg.1
Abstract
Three natural recombinant avian leukosis viruses (ALV; PDRC-1039, PDRC-3246, and PDRC-3249) expressing a subgroup A gp85 envelope protein and containing long terminal repeats (LTR) of endogenous ALV-E viruses were isolated from contaminated commercial Marek's disease vaccines, cloned, and completely sequenced. Their full genomes were analyzed and compared with representative strains of ALV. The proviral DNA of all three isolates displayed 99.3% identity to each other, suggesting a possible common ancestor, even though the contaminating viruses were obtained from three separate vaccine serials produced by two different vaccine manufacturing companies. The contaminating viruses have a genetic organization typical of replication-competent alpharetroviruses. The proviral genomes of PDRC-1039 and PDRC-3246 are 7497 bp long, and the PDRC-3249 is three base pairs shorter because of a deletion of a threonine residue within the gp85 coding region. The LTR, gag, pol, and the transmembrane (TM) region (gp37) of the env gene of all three viruses displayed high identity to endogenous counterpart sequences (>98%). Only the surface (SU) region (gp85) of the env gene displayed high identity with exogenous ALV-A (98.7%). Locus-specific polymerase chain reaction (PCR) analysis for ALV endogenous sequences (ev loci) in the chicken embryo fibroblasts used to produce the original vaccine vials identified the presence of ev-1, ev-2, ev-3, ev-4, and ev-6 in all three vaccines. Homologous recombination most likely took place to involve the SU region of the env gene because the recombinant viruses only differ in this particular region from the consensus ALV-E. These results suggest that the contaminating ALV isolates probably emerged by recombination of ALV-A with endogenous virus sequences before vaccine preparation.Keywords
This publication has 27 references indexed in Scilit:
- Molecular and Biological Characterization of a Naturally Occurring Recombinant Subgroup B Avian Leukosis Virus with a Subgroup J–Like Long Terminal RepeatAvian Diseases, 2006
- Isolation and Characterization of an Adventitious Avian Leukosis Virus Isolated from Commercial Marek's Disease VaccinesAvian Diseases, 2006
- Detection and Characterization of Avian Leukosis Virus in Marek's Disease VaccinesAvian Diseases, 2006
- Experimental Infection with Avian Leukosis Virus Isolated from Marek's Disease VaccinesAvian Diseases, 2006
- Assessing the Roles of Endogenous Retrovirus EAV-HP in Avian Leukosis Virus Subgroup J Emergence and ToleranceJournal of Virology, 2004
- Evidence for virus closely related to avian myeloblastosis-associated virus type 1 in a commercial stock of chickensAvian Pathology, 2003
- Reticuloendotheliosis Virus Sequences within the Genomes of Field Strains of Fowlpox Virus Display VariabilityJournal of Virology, 2003
- Characterization of Endogenous Avian Leukosis Viruses in Chicken Embryonic Fibroblast Substrates Used in Production of Measles and Mumps VaccinesJournal of Virology, 2001
- Unsuitability of chicken sera for detection of exogenous ALV by the group-specific antigen ELISAPublished by Wiley ,1993
- The distribution of endogenous chicken retrovirus sequences in the DNA of galliform birds does not coincide with avian phylogenetic relationshipsCell, 1979